Home/Sabiad/Prof. Jan Maarten van Dijl
PJ

Prof. Jan Maarten van Dijl

Scientific Founder (Research Lead, UMCG)

Sabiad

Therapeutic Areas

Sabiad Pipeline

DrugIndicationPhase
StaphMarkStaphylococcus aureus infections (e.g., orthopedic/surgical site infections)Pre-clinical